FDA Inspection 1002307 — Lance Sieger, M.D.
The FDA completed an inspection of Lance Sieger, M.D. on Feb 3, 2017 in Torrance, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 3, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Torrance, CA (United States)
Additional Details
Clinical Investigator (CI)